LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.

OBJECTIVE To detect the relative expression of long non-coding ribonucleic acid (lncRNA) F-box and leucine-rich repeat protein 19-antisense RNA 1 (FBXL19-AS1) in tissues and cells of non-small-cell lung cancer (NSCLC), and investigate the mechanism of lncRNA FBXL19-AS1 in promoting NSCLC cell proliferation and metastasis by regulating epithelial-mesenchymal transition (EMT) via in vitro experiments. PATIENTS AND METHODS The relative expression of lncRNA FBXL19-AS1 in NSCLC tissues and cells was detected via quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The colony formation assay was performed to study the impact of interference with lncRNA FBXL19-AS1 expression on NSCLC cell proliferation. The flow cytometry was applied to determine the influence of si-FBXL19-AS1 on the cycle distribution of NSCLC cells. After the interference with lncRNA FBXL19-AS1 expression, the transwell assay was utilized to measure the changes in the migratory and invasive abilities of NSCLC cells, while the expression changes in EMT-related molecular markers was detected via Western blotting. RESULTS The results of qRT-PCR showed that the expression of lncRNA FBXL19-AS1 in NSCLC tissues and cells was up-regulated. According to the results of the colony formation assay, the proliferative capacity of NSCLC cells was decreased after the interference with lncRNA FBXL19-AS1 expression. In flow cytometry, it was indicated that the cell cycle was arrested at the G0/G1 phase in the experimental group compared with that in the control group. The transwell assay results showed that the migratory and invasive abilities of NSCLC cells were weakened after the interference with lncRNA FBXL19-AS1 expression. The results of the Western blotting assay revealed that the expressions of EMT-related molecular markers (E-cadherin, N-cadherin, etc.) were changed. CONCLUSIONS The expression of lncRNA FBXL19-AS1 in NSCLC tissues and cells is up-regulated, and the highly expressed lncRNA FBXL19-AS1 can promote NSCLC cell proliferation and metastasis by regulating the EMT.

[1]  Xiaodong Zhang,et al.  LncRNA SNHG14 contributes to the progression of NSCLC through miR‐206/G6PD pathway , 2020, Thoracic cancer.

[2]  Xiaohu Yang,et al.  LncRNA FBXL19-AS1 promotes breast cancer cells proliferation and invasion via acting as a molecular sponge to miR-718 , 2019, Bioscience reports.

[3]  L. Fu,et al.  Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761. , 2018, European review for medical and pharmacological sciences.

[4]  X. Tian,et al.  lncRNA FBXL19-AS1 regulates osteosarcoma cell proliferation, migration and invasion by sponging miR-346 , 2018, OncoTargets and Therapy.

[5]  Jia Liu,et al.  Potential clinical application of lncRNAs in non-small cell lung cancer , 2018, OncoTargets and therapy.

[6]  Xiaohong Lv,et al.  Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  Wenyuan Zhao,et al.  Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer , 2018, Cellular Physiology and Biochemistry.

[8]  Hui Liu,et al.  Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma , 2018, Oncogene.

[9]  Yuan Yuan,et al.  Long non-coding RNA FBXL19-AS1 plays oncogenic role in colorectal cancer by sponging miR-203. , 2017, Biochemical and biophysical research communications.

[10]  Yi-Ching Wang,et al.  Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression , 2017, Molecular Cancer.

[11]  Runsheng Chen,et al.  Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits migration and invasion through Epithelial-Mesenchymal-Transition in lung cancer. , 2017, Gene.

[12]  Jie He,et al.  Cancer incidence and mortality in China in 2013: an analysis based on urbanization level , 2017, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[13]  David Atlan,et al.  Non-Coding RNAs in Lung Cancer: Contribution of Bioinformatics Analysis to the Development of Non-Invasive Diagnostic Tools , 2016, Genes.

[14]  Jing Yang,et al.  Epithelial–mesenchymal transition in tumor metastasis , 2016, Molecular oncology.

[15]  Yong Song,et al.  Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer , 2016, Medicine.

[16]  L. Crinò,et al.  Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy , 2016, Medical Oncology.

[17]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[18]  Shuhan Sun,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[19]  Zunnan Huang,et al.  Long non-coding RNA: a new player in cancer , 2013, Journal of Hematology & Oncology.